Johnson & Johnson Operating Margin 1986-2025 | JNJ
Current and historical operating margin for Johnson & Johnson (JNJ) over the last 10 years. The current operating profit margin for Johnson & Johnson as of June 30, 2025 is 28.05%.
| Johnson & Johnson Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2025-06-30 |
$90.63B |
$27.35B |
30.18% |
| 2025-03-31 |
$89.33B |
$26.60B |
29.78% |
| 2024-12-31 |
$88.82B |
$16.69B |
18.79% |
| 2024-09-30 |
$87.70B |
$17.63B |
20.10% |
| 2024-06-30 |
$86.58B |
$19.51B |
22.53% |
| 2024-03-31 |
$85.65B |
$20.06B |
23.42% |
| 2023-12-31 |
$85.16B |
$15.06B |
17.69% |
| 2023-09-30 |
$76.31B |
$12.72B |
16.67% |
| 2023-06-30 |
$74.96B |
$12.68B |
16.91% |
| 2023-03-31 |
$77.46B |
$12.21B |
15.76% |
| 2022-12-31 |
$79.99B |
$19.36B |
24.20% |
| 2022-09-30 |
$77.21B |
$18.11B |
23.46% |
| 2022-06-30 |
$80.55B |
$16.79B |
20.84% |
| 2022-03-31 |
$79.85B |
$17.61B |
22.06% |
| 2021-12-31 |
$78.74B |
$19.18B |
24.36% |
| 2021-09-30 |
$91.45B |
$19.59B |
21.42% |
| 2021-06-30 |
$89.19B |
$20.14B |
22.58% |
| 2021-03-31 |
$84.21B |
$17.42B |
20.68% |
| 2020-12-31 |
$82.58B |
$16.50B |
19.98% |
| 2020-09-30 |
$80.86B |
$19.07B |
23.58% |
| 2020-06-30 |
$80.50B |
$16.31B |
20.27% |
| 2020-03-31 |
$82.73B |
$19.42B |
23.47% |
| 2019-12-31 |
$82.06B |
$17.33B |
21.12% |
| 2019-09-30 |
$81.71B |
$16.23B |
19.87% |
| 2019-06-30 |
$81.33B |
$19.01B |
23.37% |
| 2019-03-31 |
$81.59B |
$16.94B |
20.76% |
| 2018-12-31 |
$81.58B |
$18.00B |
22.06% |
| 2018-09-30 |
$81.38B |
$17.44B |
21.43% |
| 2018-06-30 |
$80.68B |
$17.80B |
22.07% |
| 2018-03-31 |
$78.69B |
$17.58B |
22.34% |
| 2017-12-31 |
$76.45B |
$17.67B |
23.12% |
| 2017-09-30 |
$74.36B |
$19.44B |
26.14% |
| 2017-06-30 |
$72.53B |
$19.93B |
27.48% |
| 2017-03-31 |
$72.17B |
$20.08B |
27.83% |
| 2016-12-31 |
$71.89B |
$19.80B |
27.55% |
| 2016-09-30 |
$71.60B |
$19.24B |
26.87% |
| 2016-06-30 |
$70.88B |
$18.08B |
25.51% |
| 2016-03-31 |
$70.18B |
$18.92B |
26.95% |
| 2015-12-31 |
$70.07B |
$19.20B |
27.39% |
| 2015-09-30 |
$70.52B |
$18.14B |
25.73% |
| 2015-06-30 |
$71.88B |
$20.83B |
28.98% |
| 2015-03-31 |
$73.59B |
$20.71B |
28.15% |
| 2014-12-31 |
$74.33B |
$20.56B |
27.66% |
| 2014-09-30 |
$74.43B |
$20.61B |
27.69% |
| 2014-06-30 |
$73.54B |
$17.47B |
23.75% |
| 2014-03-31 |
$71.92B |
$16.63B |
23.13% |
| 2013-12-31 |
$71.31B |
$15.47B |
21.69% |
| 2013-09-30 |
$70.52B |
$15.82B |
22.44% |
| 2013-06-30 |
$69.99B |
$15.75B |
22.50% |
| 2013-03-31 |
$68.59B |
$12.99B |
18.94% |
| 2012-12-31 |
$67.22B |
$13.78B |
20.49% |
| 2012-09-30 |
$65.92B |
$10.99B |
16.68% |
| 2012-06-30 |
$64.87B |
$11.51B |
17.74% |
| 2012-03-31 |
$65.00B |
$12.90B |
19.84% |
| 2011-12-31 |
$65.03B |
$12.36B |
19.01% |
| 2011-09-30 |
$64.42B |
$14.27B |
22.15% |
| 2011-06-30 |
$63.40B |
$14.38B |
22.68% |
| 2011-03-31 |
$62.13B |
$15.18B |
24.43% |
| 2010-12-31 |
$61.59B |
$16.95B |
27.52% |
| 2010-09-30 |
$62.49B |
$17.32B |
27.72% |
| 2010-06-30 |
$62.59B |
$17.35B |
27.72% |
| 2010-03-31 |
$62.50B |
$17.39B |
27.83% |
| 2009-12-31 |
$61.90B |
$15.76B |
25.45% |
| 2009-09-30 |
$60.53B |
$16.67B |
27.54% |
| 2009-06-30 |
$61.37B |
$16.71B |
27.23% |
| 2009-03-31 |
$62.58B |
$16.83B |
26.89% |
| 2008-12-31 |
$63.75B |
$16.93B |
26.56% |
| 2008-09-30 |
$64.52B |
$15.74B |
24.40% |
| 2008-06-30 |
$63.57B |
$14.72B |
23.16% |
| 2008-03-31 |
$62.25B |
$14.38B |
23.10% |
| 2007-12-31 |
$61.10B |
$13.28B |
21.74% |
| 2007-09-30 |
$58.82B |
$13.66B |
23.22% |
| 2007-06-30 |
$57.14B |
$14.05B |
24.59% |
| 2007-03-31 |
$55.37B |
$13.62B |
24.61% |
| 2006-12-31 |
$53.32B |
$14.59B |
27.36% |
| 2006-09-30 |
$52.25B |
$14.38B |
27.52% |
| 2006-06-30 |
$51.28B |
$14.14B |
27.58% |
| 2006-03-31 |
$50.67B |
$13.80B |
27.24% |
| 2005-12-31 |
$50.51B |
$13.12B |
25.97% |
| 2005-09-30 |
$50.66B |
$12.73B |
25.13% |
| 2005-06-30 |
$49.90B |
$12.59B |
25.22% |
| 2005-03-31 |
$48.62B |
$12.75B |
26.23% |
| 2004-12-31 |
$47.35B |
$12.33B |
26.04% |
| 2004-09-30 |
$45.85B |
$12.59B |
27.45% |
| 2004-06-30 |
$44.75B |
$12.26B |
27.40% |
| 2004-03-31 |
$43.60B |
$10.88B |
24.96% |
| 2003-12-31 |
$41.86B |
$10.31B |
24.62% |
| 2003-09-30 |
$40.01B |
$9.78B |
24.45% |
| 2003-06-30 |
$38.64B |
$9.23B |
23.88% |
| 2003-03-31 |
$37.38B |
$9.60B |
25.68% |
| 2002-12-31 |
$36.30B |
$9.29B |
25.60% |
| 2002-09-30 |
$35.12B |
$8.89B |
25.30% |
| 2002-06-30 |
$34.10B |
$8.60B |
25.22% |
| 2002-03-31 |
$33.21B |
$8.30B |
25.00% |
| 2001-12-31 |
$32.32B |
$7.90B |
24.44% |
| 2001-09-30 |
$31.20B |
$7.60B |
24.36% |
| 2001-06-30 |
$30.58B |
$7.33B |
23.96% |
| 2001-03-31 |
$30.07B |
$7.11B |
23.65% |
| 2000-12-31 |
$29.54B |
$6.79B |
22.98% |
| 2000-09-30 |
$29.30B |
$6.36B |
21.72% |
| 2000-06-30 |
$28.75B |
$6.21B |
21.59% |
| 2000-03-31 |
$28.05B |
$6.06B |
21.59% |
| 1999-12-31 |
$27.47B |
$5.93B |
21.57% |
| 1999-09-30 |
$27.06B |
$6.24B |
23.05% |
| 1999-06-30 |
$25.99B |
$5.95B |
22.90% |
| 1999-03-31 |
$24.89B |
$5.62B |
22.56% |
| 1998-12-31 |
$24.00B |
$5.32B |
22.18% |
| 1998-09-30 |
$23.16B |
$5.12B |
22.12% |
| 1998-06-30 |
$22.93B |
$4.90B |
21.38% |
| 1998-03-31 |
$22.75B |
$4.76B |
20.94% |
| 1997-12-31 |
$22.63B |
$4.62B |
20.43% |
| 1997-09-30 |
$22.50B |
$8.68B |
38.58% |
| 1997-06-30 |
$22.32B |
$8.69B |
38.96% |
| 1997-03-31 |
$22.00B |
$4.44B |
20.18% |
| 1996-12-31 |
$21.62B |
$4.30B |
19.90% |
| 1996-09-30 |
$20.96B |
$0.04B |
0.17% |
| 1996-06-30 |
$20.30B |
$-0.21B |
-1.01% |
| 1996-03-31 |
$19.68B |
$3.73B |
18.93% |
| 1995-12-31 |
$18.84B |
$3.51B |
18.63% |
| 1995-09-30 |
$18.09B |
$3.43B |
18.99% |
| 1995-06-30 |
$17.39B |
$3.25B |
18.68% |
| 1995-03-31 |
$16.54B |
$3.04B |
18.40% |
| 1994-12-31 |
$14.97B |
$2.05B |
13.66% |
| 1994-09-30 |
$14.41B |
$1.94B |
13.43% |
| 1994-06-30 |
$13.88B |
$1.78B |
12.79% |
| 1994-03-31 |
$13.51B |
$1.69B |
12.53% |
| 1993-12-31 |
$14.14B |
$2.39B |
16.93% |
| 1993-09-30 |
$14.11B |
$2.35B |
16.63% |
| 1993-06-30 |
$14.08B |
$2.34B |
16.63% |
| 1993-03-31 |
$13.96B |
$2.32B |
16.65% |
| 1992-12-31 |
$13.75B |
$2.28B |
16.56% |
| 1992-09-30 |
$13.40B |
$2.31B |
17.20% |
| 1992-06-30 |
$13.04B |
$2.24B |
17.18% |
| 1992-03-31 |
$12.66B |
$2.18B |
17.19% |
| 1991-12-31 |
$12.45B |
$2.16B |
17.39% |
| 1991-09-30 |
$12.00B |
$2.08B |
17.30% |
| 1991-06-30 |
$11.75B |
$2.03B |
17.28% |
| 1991-03-31 |
$11.54B |
$1.96B |
16.96% |
| 1990-12-31 |
$11.23B |
$1.99B |
17.74% |
| 1990-09-30 |
$11.00B |
$1.98B |
17.97% |
| 1990-06-30 |
$10.59B |
$1.92B |
18.18% |
| 1990-03-31 |
$10.15B |
$1.85B |
18.18% |
| 1989-12-31 |
$9.76B |
$1.66B |
17.02% |
| 1989-09-30 |
$9.49B |
$1.56B |
16.49% |
| 1989-06-30 |
$9.23B |
$1.49B |
16.10% |
| 1989-03-31 |
$9.13B |
$1.46B |
15.93% |
| 1988-12-31 |
$9.00B |
$1.40B |
15.60% |
| 1988-09-30 |
$8.73B |
$1.30B |
14.89% |
| 1988-06-30 |
$8.57B |
$1.30B |
15.18% |
| 1988-03-31 |
$8.34B |
$1.30B |
15.60% |
| 1987-12-31 |
$8.01B |
$1.21B |
15.09% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
